Lawrence Friedhoff
Chairman at Pharmaceutical Special Projects Group, LLC | Westwood, New Jersey, United States
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Chairman at Pharmaceutical Special Projects Group, LLC in February 2004 to Present
Chief Executive Officer at Pharmaceutical Special Projects Group, LLC in February 2004 to Present
Advisor at Roivant Sciences in June 2018 to December 2018
Chief R&D at Roivant Sciences in January 2014 to June 2018
Chief Development Officer at Axovant Sciences in January 2015 to September 2017
Executive Vice President, Research and Development at Andrx in August 1998 to November 2003
Executive Vice President, R&D at Eisai in September 1988 to March 1998
Clinical Pharmacology Director at Bristol-Myers Squibb in January 1984 to January 1988
See more
See less
Consistently obtaining approvals of new drugs
Approvals
Pharmaceutical Industry
FDA
Biotechnology
Clinical Development
Technology Transfer
Clinical Trials
Lifesciences
Regulatory Affairs
Biopharmaceuticals
Oncology
Drug Development
Validation
Infectious Diseases
Licensing
Neuroscience
IND
Biochemistry
Sop
Genetics
Drug Discovery
Regulatory Submissions
Cell Biology
GMP
R&D
Cancer
Clinical Research
Pharmaceutics
Commercialization
21 CFR Part 11
CRO
HPLC
Hardware Diagnostics
Immunology
Pharmacology
Life Sciences
SOP
Strategy
Medicine
U.S. Food and Drug Administration (FDA)
Research and Development (R&D)
Standard Operating Procedure (SOP)
See more
See less
What is Lawrence Friedhoff email address?
Email Lawrence Friedhoff at [email protected] and [email protected]. This email is the most updated Lawrence Friedhoff email found in 2026.
What is Lawrence Friedhoff phone number?
Lawrence Friedhoff phone number is +12013217181 and +12013211058.
How to contact Lawrence Friedhoff?
To contact Lawrence Friedhoff send an email to [email protected] or [email protected]. If you want to call Lawrence Friedhoff try calling on +12013217181 and +12013211058. (updated on August 26, 2024)
What is Lawrence Friedhoff net worth?
Lawrence Friedhoff has an estimated net worth of $750,000 to $999,999
What company does Lawrence Friedhoff work for?
Lawrence Friedhoff works for Pharmaceutical Special Projects Group, LLC
What is Lawrence Friedhoff's role at Pharmaceutical Special Projects Group, LLC?
Lawrence Friedhoff is Chairman
Lawrence Friedhoff Email Addresses
Lawrence Friedhoff Phone Numbers
looking for?
Find personal and work emails for over 250M professionals.
People like Lawrence Friedhoff
F&I Manger at Jack Garrett Ford
Founder at Wholesale Supply Chain Company
Regional Service Manager at Daikin Applied Americas
Senior Manager, Global Corporate Marketing at Cushman & Wakefield
Staff Tech Lead Manager - Failure Analysis at Cruise
Account Manager at RUSCO PACKAGING INC
Co-Founder and CEO at Class II Solutions, LLC
Excutive Vice President of Sales for Jack Kelege at Jack Kelege
Real Estate Agent at Central Metro Realty
Senior Director of Development Communications and Strategic Engagement at Ed Farm
Health Services Manager at United States Air Force
#IAmRemarkable Facilitator at g.co/IAmRemarkable
Director, Teacher Leadership Development at Teach For America
Business Analytics Manager at Essex Brownell
Director of Hardware Engineering at BioTelemetry, a Philips company
Employee Relations Director at City and County of San Francisco
Project Accountant at Zimmer Gunsul Frasca Architects LLP
Sales Manager at Junge Automotive Group
Principal Scientist at Saint-Gobain Northboro R&D Center
Staff Attorney at Indiana Legal Services, Inc.
Show more
Show less